IDEX stock has delivered a strong 47.2% return over the past year, while its valuation checks send mixed messages, with a Discounted Cash Flow (DCF) estimate pointing to some upside against market multiples that lean expensive.

• Over the last 12 months, IDEX shares have returned 47.2%, which puts extra focus on whether recent gains are backed by fundamentals.
• The intrinsic value estimate from a Discounted Cash Flow (DCF) model suggests the stock trades about 13.2% below that assessment, although any slowdown in future cash flow growth or higher required returns could quickly change that picture.
• IDEX currently passes only 2 out of 6 valuation checks, which implies the broader set of tests at 2/6 leans more towards the stock being on the expensive side rather than a clear bargain.

The issue now is whether investors should treat IDEX as a stock with remaining potential based on intrinsic value, or one where the recent rally and richer multiples leave limited room for error.

Does IDEX Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) method estimates what IDEX is worth today based on the cash it is expected to generate in the future. For IDEX, the model starts with latest twelve month free cash flow of about $641.9 million in reporting currency and then assumes growing cash flows over time, which fits a mature but still expanding business profile rather than a turnaround story.

On these assumptions, the DCF model arrives at an intrinsic value of about $275 per share. That sits above the current share price, which implies the stock trades at roughly a 13.2% discount to this cash flow based estimate. The key caveat is that this outcome depends on continued growth in free cash flow and a stable required return, so any shift in those inputs would move the fair value.

On balance, the Discounted Cash Flow work suggests IDEX currently looks undervalued relative to its projected cash generation.

Our Discounted Cash Flow (DCF) analysis suggests IDEX is undervalued by 13.2%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.

Is IDEX Getting Expensive on Earnings?

The P/E ratio is a useful way to check how much investors are paying for each dollar of IDEX earnings. IDEX currently trades on a P/E of about 33.9x, compared with an average of roughly 27.6x for Machinery industry peers.

A more tailored model that looks at IDEX growth profile, profitability, size and risk points to a fair P/E of about 26.0x. That is below the present 33.9x market multiple. It suggests investors are paying a premium to both the industry average and what this framework would usually assign to the stock based on its fundamentals.

Taken together, these comparisons indicate that IDEX stock appears overvalued on its current P/E multiple.

The IDEX Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for IDEX pick up where the valuation checks leave off. They set out the specific assumptions on growth, margins and earnings that would need to play out for IDEX's stock to be worth materially more or materially less than today's price, and they sit on Simply Wall St's Community page. Where a ratio or model gives one figure, these narratives describe the future that figure relies on so you can see whether reality is lining up.

You can add your voice to the Simply Wall St community on IDEX by setting out a clear, number driven narrative on where its growth, margins and execution go from here. Share a case you can track over time and see how it stacks up as new results arrive.

Do you think there's more to the story for IDEX? Head over to our Community to see what others are saying!

The Bottom Line

IDEX sits in a grey zone where the Discounted Cash Flow (DCF) intrinsic value points to undervaluation, while the P/E based view flags the stock as overvalued relative to peers and a tailored fair multiple. The weak broader valuation checks suggest investors should treat the DCF signal with caution rather than as a clear green light. The split mainly reflects different weight on long term cash generation versus what the market is currently willing to pay for IDEX growth. The crux from here is whether the company can deliver cash flows that justify both the intrinsic value estimate and the premium earnings multiple.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.